Kate Collins

Miss Kate Collins

Research Assistant

School of Pharmacy and Biomedical Sciences

College of Health

Year Citation
2026 Kamath, S., Sokolenko, E., Collins, K., Chan, N. S. L., Mills, N., Clark, S. R., . . . Joyce, P. (2026). IUPHAR Themed Review: The Gut Microbiome in Schizophrenia.. Pharmacological Research, 211(107561), 107561-1-107561-13.
DOI Scopus24 WoS20 Europe PMC18
2026 Collins, K., Donnellan, L., Asif, Z., Chan, N. S. L., Subramaniam, S., Kamath, S., . . . Joyce, P. (2026). The gut microbiome modulates the lipase-mediated digestion of dietary lipid emulsions. Colloids and Surfaces B: Biointerfaces, 265, 115715-1-115715-14.
DOI Scopus3 WoS2 Europe PMC2
2026 Khetan, R., Donnellan, L., Collins, K., Kamath, S., Ariaee, A., Rajapaksha, W., . . . Joyce, P. (2026). The gut microbiota regulates the protein corona formation, biodistribution, and cellular uptake of lipid nanoparticles. Journal of Controlled Release, 395, 114995-1-114995-15.
DOI
2026 Collins, K., Kamath, S., Davis, R. H., Costello, S. P., Bryant, R. V., Day, A. S., & Joyce, P. (2026). Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy. Alimentary Pharmacology and Therapeutics, 64(6), 729-747.
DOI
2025 Kamath, S., Ariaee, A., Abdelhafez, A., Asif, Z., Chan, N. S. L., Collins, K., . . . Joyce, P. (2025). Microbiome-active drug delivery systems (MADDS): leveraging microbial stimuli for controlled drug release. Advanced Drug Delivery Reviews, 227(115720), 1-23.
DOI Scopus19 WoS18 Europe PMC7
2024 Kamath, S., Hunter, A., Collins, K., Wignall, A., & Joyce, P. (2024). The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats. British Journal of Pharmacology, 181(22), 4531-4545.
DOI Scopus23 WoS23 Europe PMC20

Connect With Me

External Profiles

Other Links